We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
Find information from the Race Disparity Unit about the experiences of people from different ethnic backgrounds in areas including health, education, employment, housing, work, and criminal justice.
Cambios de color en la piel del dorado (Mahi-mahi, Coryphaena hippurus)
Government outlines action to make UK a world leader in tackling ethnic and other biases in medical devices.
Get help to classify textiles and which headings and codes to use.
Documents of the NRPB volume 8 number 3 includes information on assessing doses of radiation to the skin.
A facial recognition service provider used Credo AI’s platform to provide transparency on fairness and performance evaluations of its identity verification service to its customers.
This History Note attempts to document the history of race at the Foreign Office on how present-day approach towards non-white staff developed.
The Medicines and Healthcare products Regulatory Agency (MHRA) is advising anyone experiencing skin redness or burning sensations after they have stopped using these creams or ointments to seek advice from their health professional before using these products again.
Rarely, severe adverse effects can occur on stopping treatment with topical corticosteroids, often after long-term continuous or inappropriate use of moderate to high potency products. To reduce the risks of these events, prescribe the topical corticosteroid of lowest potency needed...
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey.